Literature DB >> 7986926

Visceral leishmaniasis following treatment with liposomal amphotericin B.

M McBride, M Linney, E J Claydon, J Weber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7986926     DOI： 10.1093/clinids/19.2.362

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

Review 1.  Leishmania and human immunodeficiency virus coinfection: the first 10 years.

Authors:  J Alvar; C Cañavate; B Gutiérrez-Solar; M Jiménez; F Laguna; R López-Vélez; R Molina; J Moreno
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

2.  Liposomal amphotericin B therapy of murine histoplasmosis.

Authors:  J R Graybill; R Bocanegra
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

3.  Miltefosine (Impavido): the first oral treatment against leishmaniasis.

Authors:  H Sindermann; S L Croft; K R Engel; W Bommer; H J Eibl; C Unger; J Engel
Journal:  Med Microbiol Immunol       Date:  2003-09-26       Impact factor: 3.402

4.  Targeting intracellular Leishmania (L.) infantum with nitazoxanide entrapped into phosphatidylserine-nanoliposomes: An experimental study.

Authors:  Erika Gracielle Pinto; Leandro R S Barbosa; Renato A Mortara; Andre Gustavo Tempone
Journal:  Chem Biol Interact       Date:  2020-10-20       Impact factor: 5.192
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.